Benzinga | Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals

Market Overview

87.39 0 (0%)

Data as of Apr 26, 2018

Prev. Close 87.39
Price Open
Volume 0
Day's Range -
52 Wk Range 50.1001 - 92.31
50 Day Moving Avg. 86.92
PE Ratio 78.026786
Shares Outstanding 48.19M
Market Cap 4.21B

Trade LIVN stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

LivaNova Receives CE Mark for VNS Therapy SenTiva Generator for Treatment of Epilepsy Paul QuintaroTue, 17 Apr 2018 08:15:38 -0400
LivaNova Reports Bicarbon Aortic Valves Received CE Mark For Expanded-Use Labeling Paul QuintaroThu, 29 Mar 2018 09:02:44 -0400
LivaNova Enters into Definitive Agreement to Divest Its Cardiac Rhythm Management Business Franchise to MicroPort Scientific for $190M in Cash Charles GrossThu, 08 Mar 2018 04:48:21 -0400
Canaccord Genuity Maintains Hold on LivaNova, Raises Price Target to $83.00 Vick MeyerThu, 01 Mar 2018 12:35:49 -0400
LivaNova Sees FY18 Adj. EPS $3.40-$3.60 vs $3.49 Est., Sales Growth Of 4-6% Eddie StaleyWed, 28 Feb 2018 08:04:57 -0400
LivaNova Reports Q4 EPS $0.88 vs $0.77 Est., Sales $278.4M vs $262M Est. Eddie StaleyWed, 28 Feb 2018 08:04:31 -0400
LivaNova To Acquire TandemLife For $250M Hal LindonWed, 14 Feb 2018 17:45:17 -0400
LivaNova Announces CE Mark for PureFlex Arterial Cannulae Line for Conventional Cardiac Surgery Eddie StaleyThu, 01 Feb 2018 10:46:20 -0400
LivaNova Reports Initiation Of BELIEVE Aortic Heart Valve Study In US, Canada Paul QuintaroThu, 11 Jan 2018 10:04:40 -0400
LivaNova Reports Commencement Of Global RESTORE-LIFE Study For Treatment-Resistant Depression Paul QuintaroThu, 04 Jan 2018 13:49:31 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

New Research: Key Drivers of Growth for Bonanza Creek Energy, MarketAxess, LivaNova, Cintas, Bio-Techne, and Provident Financial Services — Factors of Influence, Major Initiatives and Sustained Production Globe NewswireApr 18, 2018
LivaNova to Host Conference Call for First Quarter 2018 Results Business WireApr 05, 2018
LivaNova Completes Acquisition of TandemLife Business WireApr 04, 2018
LivaNova Commences Clinical Study to Evaluate Treatment Outcomes for Novel Microburst VNS Therapy System Business WireMar 28, 2018
LivaNova Announces Enrollment for PERFECT Perceval Valve Clinical Trial in China Business WireMar 22, 2018
LivaNova to Present at the Needham & Company Healthcare Conference Business WireMar 20, 2018
Report: Developing Opportunities within AveXis, LivaNova, FRP, Ross Stores, R1 RCM, and Criteo S.A — Future Expectations, Projections Moving into 2018 Globe NewswireMar 14, 2018
LivaNova Enters into Definitive Agreement to Divest Its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation Business WireMar 08, 2018
LivaNova Reports Fourth Quarter and Full-Year 2017 Results Business WireFeb 28, 2018
Livanova PLC to Host Earnings Call PRLiveFeb 28, 2018
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

New Research: Key Drivers of Growth for Bonanza Creek Energy, MarketAxess, LivaNova, Cintas, ... GuruFocusApr 18, 2018
LivaNova completes TandemLife buy Seeking AlphaApr 04, 2018
Enrollment underway in China study of LivaNova's Perceval Valve Seeking AlphaMar 22, 2018
LivaNova PLC (LIVN) Presents At Barclays Global Healthcare Conference 2018 - Slideshow Seeking AlphaMar 14, 2018
LivaNova to divest CRM unit Seeking AlphaMar 08, 2018
LivaNova's (LIVN) CEO Damien McDonald on Q4 2017 Results - Earnings Call Transcript Seeking AlphaFeb 28, 2018
LivaNova PLC beats by $0.11, beats on revenue Seeking AlphaFeb 28, 2018
Notable earnings before Wednesday's open Seeking AlphaFeb 27, 2018
Tracking George Soros's Portfolio - Q4 2017 Update Seeking AlphaFeb 18, 2018
Hermes Investment Management Ltd Buys Taiwan Semiconductor Manufacturing Co, JD. ... GuruFocusJan 24, 2018
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Earnings View Earnings

Q4 2017	EST	Actual	Surprise
EPS:	0.75	0.88	0.13
Rev:	262.85M	278.40M	15.55M

Q1 2018	EST	Actual	Surprise
EPS:	0.65	Expected 2018-05-02
Rev:	243.42M	Expected 2018-05-02

Brokerage Center

Compare All Online Brokerages